Immunome had a revenue of 0.00 in the quarter ending Sep 30, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 9.68M, Increased -23.12%. In the fiscal year ending Dec 31, 2024, Immunome had annual revenue of 9.04M with -35.50% growth.